DIFFERENTIAL UPTAKE OF IMMUNO-ONCOLOGY (IO) TREATMENTS AMONG DIFFERENT INCOME LEVELS FOR NON-SMALL CELL CANCER PATIENTS IN CHINA

被引：0
|
作者：
De Richter, P. [1 ]
机构：
[1] Ipsos, Kuala Lumpur 14, Malaysia
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN246
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Atezolizumab in non-small cell lung cancer: the era of precision immuno-oncology
    Chow, James Chung Hang
    Cheung, Ka Man
    Cho, William Chi Shing
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (12)
  • [2] Dual immuno-oncology agents as neoadjuvant therapy for patients with resectable non-small cell lung cancer
    Adachi, Hiroyuki
    Ito, Hiroyuki
    Nagashima, Takuya
    Isaka, Tetsuya
    Saito, Aya
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (02) : 229 - 235
  • [3] Diffusion of innovation in oncology: A case study of immuno-oncology (IO) adoption for advanced non-small lung cancer (aNSCLC) patients across practices in the US
    Bennette, Caroline Savage
    Torres, Aracelis Z.
    Tucker, Melisa
    Khozin, Sean
    Abernethy, Amy Pickar
    Brown, Nicholas R.
    Meropol, Neal J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Personalized medicine in immuno-oncology: a novel prognostic index in non-small cell lung cancer
    Majeed, Habeeb
    Amir, Eitan
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S995 - S998
  • [5] Neoadjuvant and consolidation immuno-oncology therapy in stage III non-small cell lung cancer
    Yeh, Justin
    Marrone, Kristen A.
    Forde, Patrick M.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S451 - S459
  • [6] PROFILES OF NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH IMMUNO-ONCOLOGY THERAPIES IN THE UNITED STATES AND WESTERN EUROPE
    Shah-Manek, B.
    Karki, C.
    Whitmire, S. M.
    Ilacqua, J.
    Wriede, V
    [J]. VALUE IN HEALTH, 2018, 21 : S40 - S40
  • [7] Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction
    Socinski, Mark A.
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (05) : S1 - S2
  • [8] Real-World (RW) Predictors of Immuno-Oncology (IO) vs Chemotherapy (C) Use in Advanced Non-Small Cell Lung Cancer (aNSCLC)
    Radtchenko, J.
    Korytowsky, B.
    Nwokeji, E.
    Tue, K.
    Feinberg, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S889 - S889
  • [9] Revamping Non-Small Cell Lung Cancer Treatments in Stages II and III: Preparing Healthcare for Cutting-Edge Immuno-Oncology Regimens
    Bertolaccini, Luca
    Casiraghi, Monica
    Bardoni, Claudia
    Diotti, Cristina
    Chiari, Matteo
    Mazzella, Antonio
    de Marinis, Filippo
    Spaggiari, Lorenzo
    [J]. CANCERS, 2024, 16 (16)
  • [10] Comparison of availability and accessibility of Immuno-oncology (IO) drugs for cancer treatment among Japan, Korea, China and Taiwan
    Lo, Joanne
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 139 - 139
12345